Simona S Ghanem1, Harrison T Muturi2, Anthony M DeAngelis1, Jiang Hu3, Rohit N Kulkarni3, Garrett Heinrich2,4, Sonia M Najjar5,6,7. 1. Center for Diabetes and Endocrine Research, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA. 2. Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA. 3. Section on Islet Cell and Regenerative Biology, Joslin Diabetes Center and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard Stem Cell Institute, Boston, MA, USA. 4. Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, 45701-2979, USA. 5. Center for Diabetes and Endocrine Research, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA. najjar@ohio.edu. 6. Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USA. najjar@ohio.edu. 7. Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, 45701-2979, USA. najjar@ohio.edu.
Abstract
AIMS/HYPOTHESIS: Cc2 -/- mice lacking the gene encoding the carcinoembryonic-antigen-related cell adhesion molecule 2 (Cc2 [also known as Ceacam2]) exhibit hyperphagia that leads to obesity and insulin resistance. This starts at 2 months of age in female mice. Male mutants maintain normal body weight and insulin sensitivity until the last age previously examined (7-8 months), owing to increased sympathetic tone to white adipose tissue and energy expenditure. The current study investigates whether insulin resistance develops in mutant male mice at a later age and whether this is accompanied by changes in insulin homeostasis. METHODS: Insulin response was assessed by insulin and glucose tolerance tests. Energy balance was analysed by indirect calorimetry. RESULTS: Male Cc2 -/- mice developed overt metabolic abnormalities at about 9 months of age. These include elevated global fat mass, hyperinsulinaemia and insulin resistance (as determined by glucose and insulin intolerance, fed hyperglycaemia and decreased insulin signalling pathways). Pair-feeding experiments showed that insulin resistance resulted from hyperphagia. Indirect calorimetry demonstrated that older mutant male mice had compromised energy expenditure. Despite increased insulin secretion caused by Cc2 deletion, chronic hyperinsulinaemia did not develop in mutant male mice until about 9 months of age, at which point insulin clearance began to decline substantially. This was probably mediated by a marked decrease in hepatic CEACAM1 expression. CONCLUSIONS/ INTERPRETATION: The data demonstrate that at about 9 months of age, Cc2 -/- male mice develop a reduction in energy expenditure and energy imbalance which, combined with a progressive decrease in CEACAM1-dependent hepatic insulin clearance, causes chronic hyperinsulinaemia and sustained age-dependent insulin resistance. This represents a novel mechanistic underpinning of age-related impairment of hepatic insulin clearance.
AIMS/HYPOTHESIS: Cc2 -/- mice lacking the gene encoding the carcinoembryonic-antigen-related cell adhesion molecule 2 (Cc2 [also known as Ceacam2]) exhibit hyperphagia that leads to obesity and insulin resistance. This starts at 2 months of age in female mice. Male mutants maintain normal body weight and insulin sensitivity until the last age previously examined (7-8 months), owing to increased sympathetic tone to white adipose tissue and energy expenditure. The current study investigates whether insulin resistance develops in mutant male mice at a later age and whether this is accompanied by changes in insulin homeostasis. METHODS: Insulin response was assessed by insulin and glucose tolerance tests. Energy balance was analysed by indirect calorimetry. RESULTS: Male Cc2 -/- mice developed overt metabolic abnormalities at about 9 months of age. These include elevated global fat mass, hyperinsulinaemia and insulin resistance (as determined by glucose and insulin intolerance, fed hyperglycaemia and decreased insulin signalling pathways). Pair-feeding experiments showed that insulin resistance resulted from hyperphagia. Indirect calorimetry demonstrated that older mutant male mice had compromised energy expenditure. Despite increased insulin secretion caused by Cc2 deletion, chronic hyperinsulinaemia did not develop in mutant male mice until about 9 months of age, at which point insulin clearance began to decline substantially. This was probably mediated by a marked decrease in hepatic CEACAM1 expression. CONCLUSIONS/ INTERPRETATION: The data demonstrate that at about 9 months of age, Cc2 -/- male mice develop a reduction in energy expenditure and energy imbalance which, combined with a progressive decrease in CEACAM1-dependent hepatic insulin clearance, causes chronic hyperinsulinaemia and sustained age-dependent insulin resistance. This represents a novel mechanistic underpinning of age-related impairment of hepatic insulin clearance.
Authors: Timothy R Koves; John R Ussher; Robert C Noland; Dorothy Slentz; Merrie Mosedale; Olga Ilkayeva; James Bain; Robert Stevens; Jason R B Dyck; Christopher B Newgard; Gary D Lopaschuk; Deborah M Muoio Journal: Cell Metab Date: 2008-01 Impact factor: 27.287
Authors: P R Patel; S K Ramakrishnan; M K Kaw; C K Raphael; S Ghosh; J S Marino; G Heinrich; S J Lee; R E Bourey; J W Hill; D Y Jung; D A Morgan; J K Kim; K Rahmouni; S K Rahmouni; S M Najjar Journal: Diabetologia Date: 2011-12-11 Impact factor: 10.122
Authors: P Nédellec; G S Dveksler; E Daniels; C Turbide; B Chow; A A Basile; K V Holmes; N Beauchemin Journal: J Virol Date: 1994-07 Impact factor: 5.103
Authors: Qusai Y Al-Share; Anthony M DeAngelis; Sumona Ghosh Lester; Thomas A Bowman; Sadeesh K Ramakrishnan; Simon L Abdallah; Lucia Russo; Payal R Patel; Meenakshi K Kaw; Christian K Raphael; Andrea Jung Kim; Garrett Heinrich; Abraham D Lee; Jason K Kim; Rohit N Kulkarni; William M Philbrick; Sonia M Najjar Journal: Diabetes Date: 2015-05-13 Impact factor: 9.461
Authors: C Christine Lee; Steven M Haffner; Lynne E Wagenknecht; Carlos Lorenzo; Jill M Norris; Richard N Bergman; Darko Stefanovski; Andrea M Anderson; Jerome I Rotter; Mark O Goodarzi; Anthony J Hanley Journal: Diabetes Care Date: 2012-12-05 Impact factor: 19.112
Authors: Hong Wang; Leslie A Knaub; Dalan R Jensen; Dae Young Jung; Eun-Gyoung Hong; Hwi-Jin Ko; Alison M Coates; Ira J Goldberg; Becky A de la Houssaye; Rachel C Janssen; Carrie E McCurdy; Shaikh M Rahman; Cheol Soo Choi; Gerald I Shulman; Jason K Kim; Jacob E Friedman; Robert H Eckel Journal: Diabetes Date: 2008-10-24 Impact factor: 9.461
Authors: Hilda E Ghadieh; Lucia Russo; Harrison T Muturi; Simona S Ghanem; Iyad H Manaserh; Hye Lim Noh; Sujin Suk; Jason K Kim; Jennifer W Hill; Sonia M Najjar Journal: Metabolism Date: 2019-01-19 Impact factor: 8.694